I. Giere

发表

Structural aberrations of chromosomes 17 and 12 in chronic B‐cell disorders

M. Narbaitz, Christian Chena, G. Arrossagaray, 2003, European journal of haematology.

Spontaneous breakage and fragile site expression in chronic lymphocytic leukemia.

I. Slavutsky, I. Larripa, A. Fundia, 1998, Cancer genetics and cytogenetics.

Programme for Harmonization to the International Scale in Latin America for BCR-ABL1 quantification in CML patients: findings and recommendations

M. Gutiérrez, C. Santamaria, M. E. Altuna, 2020, Clinical chemistry and laboratory medicine.

Planned Pregnancy in a Chronic Myeloid Leukemia Patient in Molecular Remission

C. Pavlovsky, I. Giere, G. Van Thillo, 2012, Case reports in hematology.

Treatment-free remission in patients with chronic myeloid leukemia: recommendations of the LALNET expert panel

J. Cortes, M. Bianchini, V. Funke, 2021, Blood advances.

TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcome.

R. Bengió, I. Larripa, C. Ferri, 2016, Blood cells, molecules & diseases.

Molecular study of the interferon genes in chronic myeloid leukemia.

I. Slavutsky, I. Larripa, I. Giere, 1995, Leukemia research.

Complex Karyotype with PH1 Chromosome in Myelodysplasia: Cytogenetic and Molecular Studies

M. Gutiérrez, I. Slavutsky, R. Bengió, 1992 .

Molecular monitoring of imatinib in chronic myeloid leukemia patients in complete cytogenetic remission: does achievement of a stable major molecular response at any time point identify a privileged group of patients? A multicenter experience in Argentina and Uruguay.

Juan F. García, R. Bengió, M. Pavlovsky, 2011, Clinical lymphoma, myeloma & leukemia.

Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia

C. Corrado, S. Sapia, M. Pavlovsky, 2006, Cytometry. Part B, Clinical cytometry.

First Latin America report on the diagnostic utility of the study of the MYD88 L265P gene mutation in patients with Waldenström Macroglobulinemia

J. Castillo, F. Giuliani, G. Remaggi, 2022, Annals of Hematology.

Clinical relevance of the breakpoint sites within the M-BCR in 50 patients from Argentina with chronic myeloid leukemia.

I. Larripa, I. Giere, 1996, Leukemia & lymphoma.

GSTM1 and GSTP1, but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response.

R. Bengió, I. Larripa, C. Ferri, 2016, Cancer epidemiology.

Elevated plasma levels of IL-6 and MCP-1 selectively identify CML patients who better sustain molecular remission after TKI withdrawal

M. Bianchini, E. Levy, J. Mordoh, 2023, Journal of Hematology & Oncology.

Cytogenetic and molecular studies of variant Ph' translocations.

I. Slavutsky, R. Bengió, I. Larripa, 2000, Haematologica.